Anlon Healthcare Limited announced its audited financial results for the quarter and financial year ended March 31, 2026, during a Board Meeting held on May 29, 2026. The company reported a standalone revenue from operations of 5,542.22 Lacs for the current quarter, compared to 3,557.80 Lacs in the previous quarter and 4,892.71 Lacs in the corresponding quarter of the previous year. Standalone profit after tax for the period stood at 979.20 Lacs, versus 515.20 Lacs in the previous quarter and 1,664.78 Lacs in the corresponding quarter last year.

Anlon Healthcare Limited, based in Rajkot, India, is a research-intensive manufacturing company specializing in the production of Active Pharmaceutical Ingredients (APIs) and drug intermediates. The company has established a global presence, producing high-quality pharmaceutical bulk drugs that meet stringent international standards. Shares of the company are listed on both the National Stock Exchange of India (NSE) under the symbol “AHCL” and the BSE Limited under the code 544497. The company has two subsidiaries: Bizotic Lifescience Private Limited and Apiqo Organics Private Limited.